Three States Challenge FDA’s Approval of Generic Abortion Pill

Missouri, Idaho, and Kansas updated their complaint in an ongoing legal battle against the FDA’s loosened restrictions that eased access to the abortion pill mifepristone, challenging the agency’s most recent approval of a generic version of the drug.